SCHEMBL658395

SCHEMBL658395

Nc1nccc2cc(Cl)oc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 2/20 0.54
CDK9 P50750 1/20 0.39
DYRK1A Q13627 1/20 0.39
NOS3 P29474 4/20 0.38
NOS2 P35228 4/20 0.38
F12 P00748 2/20 0.38
NOS1 P29475 2/20 0.38
PLAU P00749 1/20 0.38
NCF1 P14598 1/20 0.38
BACE1 P56817 1/20 0.38
MAP4K4 O95819 1/20 0.38
ROCK1 Q13464 3/20 0.36
PLG P00747 1/20 0.33
F11 P03951 1/20 0.33
KLKB1 P03952 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33
JAK2 O60674 1/20 0.33
TYK2 P29597 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8267507 0.77 TLR8 (0.58) TLR8DYRK1ANOS3NOS2F12
SCHEMBL10217290 0.77 TLR8 (0.54) TLR8NOS3NOS2F12NOS1
SCHEMBL16650795 0.77 JAK2 (0.35) TLR8CDK9DYRK1AJAK2TYK2
SCHEMBL10217272 0.77 CYP2A6 (0.38) TLR8CDK9DYRK1AJAK2TYK2
SCHEMBL16651306 0.74 ALDH1A1 (0.35) TLR8NOS3NOS2NOS1JAK2
SCHEMBL659026 0.72 RAB9A (0.58) TLR8NOS3NOS2F12NOS1
SCHEMBL15231528 0.72 TLR8 (0.49) TLR8LMNA
SCHEMBL16836460 0.70 TLR8 (1.00) TLR8NOS3NOS2F12NOS1
SCHEMBL21999292 0.69 TLR8 (0.66) TLR8NOS3NOS2F12NOS1
SCHEMBL16836323 0.68 TLR8 (1.00) TLR8NOS3NOS2ROCK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 TLR8 2644/4885CDK9 232/4885DYRK1A 2154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.